Top EDC Vendors in 2026: Choosing the Right Platform for Your Clinical Trials

|Todas AB

Selecting an Electronic Data Capture (EDC) system is one of the most consequential decisions in clinical trial planning. The platform you choose shapes how data is collected, validated, monitored, and ultimately submitted to regulatory agencies. It affects study build timelines, site satisfaction, data quality, and total cost of ownership.

The EDC market has matured significantly in recent years. As of 2024, the global EDC systems market was valued at approximately $1.88 billion and is projected to grow at a compound annual growth rate of over 10% through 2032. This growth is driven by the increasing complexity of clinical trials, the expansion of decentralized trial designs, and the demand for integrated eClinical platforms that connect data capture with randomization, safety reporting, and clinical operations.

Best EDC Vendor by Use Case in 2026

Clinical data management teams come to this guide with very different starting points — a small CRO running its first multi-site trial, a biotech preparing a pivotal Phase II, a sponsor consolidating onto one enterprise platform. The table below maps the most common use cases to the vendors that match them, with a link to the relevant section below.

Use case Top vendors to evaluate Why
Large pharma · Phase II–IV global trials Medidata Rave, Oracle Clinical One, Veeva Vault EDC Enterprise scale, full eClinical suite, broad CRO ecosystem
Mid-size pharma seeking flexibility Viedoc, Veeva Vault EDC, eCaseLink Modular pricing, integrated suite, faster build cycles
Small CROs and biotechs running multiple trials Viedoc, Medrio, Castor Cost-effective per-trial pricing, no-code build, fast deployment
Biotech with fast study startup needs Castor, Medrio, TrialOnline 1–3 hour training, drag-and-drop CRF design, rapid go-live
Decentralized and hybrid trial designs Medidata, Castor, Medrio, Oracle Clinical One Patient-facing data capture, eCOA, wearable integration
Medical device trials Castor, Viedoc, Medrio Lighter regulatory overhead, ISO 27001, intuitive UI
Academic and investigator-initiated OpenClinica, REDCap Cloud, Castor Lower cost, validated environments, familiar tooling
Phase I oncology with intensive PK sampling Medidata Rave, Medrio, Viedoc Flexible visit scheduling, precise timestamping

For the full profile of each vendor — capabilities, recent product developments, and ideal customer fit — read the relevant section below.

This guide profiles the leading EDC vendors in 2026, organized by market segment, to help clinical data management professionals, sponsors, and CROs evaluate their options based on verified capabilities and positioning. For a broader view of the broader EDC technology landscape, see our pillar article.

How to Use This Guide

No single EDC platform is best for every organization or every trial. The right choice depends on your trial portfolio's size and complexity, your integration requirements, your internal technical capabilities, and your budget. This guide presents vendors across three categories: enterprise platforms suited for large multinational trials, mid-market platforms offering flexibility and value for growing organizations, and academic and open-source solutions designed for research institutions and smaller budgets.

For a detailed framework on evaluating these vendors against your specific requirements, see our guide to trial-level EDC system selection. If you are making a strategic decision across your entire clinical programme, our guide to company-level EDC selection covers that process.

Enterprise EDC Platforms

Medidata Rave EDC

Medidata, a Dassault Systèmes brand headquartered in New York City, operates the largest EDC platform in the clinical trial industry. According to the company's own published figures, Medidata Rave EDC has been used in more than 34,000 trials involving over 10 million patients. The platform serves approximately 2,200 customers with more than one million registered users globally.

Medidata has been recognized as a Leader by both Everest Group and IDC in their respective EDC assessments. The platform forms the core of the broader Medidata Clinical Cloud, which integrates EDC with eCOA, RTSM, eTMF, medical coding, imaging, and safety reporting in a unified ecosystem.

Key capabilities include advanced edit checks with AI-powered data cleaning, Clinical Data Studio for real-time data integration and centralized monitoring, and Rave Companion — a tool introduced in 2025 that enables research coordinators to auto-populate EDC forms with verified electronic health record (EHR) data, reportedly accelerating data entry by up to 90%. In late 2024, Medidata also launched Rave Lite, extending access to its EDC technology for Phase I and Phase IV studies with a tailored pricing model.

Best suited for: Large pharmaceutical companies, global CROs, and complex multinational Phase II–IV trials requiring comprehensive integration across the eClinical ecosystem.

Oracle Clinical One

Oracle Life Sciences offers Clinical One as a unified cloud platform that brings together electronic data capture, randomization and trial supply management (RTSM), and safety reporting within a single environment. Unlike traditional EDC systems that focus primarily on form-based data collection, Clinical One is designed to capture data from multiple sources including eCRFs, wearable devices, patient applications, EHR systems, and central laboratories.

In August 2025, Oracle introduced significant enhancements including AI-enabled EHR interoperability for secure, automated data transfer between health record systems and the EDC platform, expanded document management capabilities at the subject level, and integrated safety reporting using the ICH E2B(R3) standard with full interoperability with Oracle Safety One Argus.

The platform's RTSM module supports randomization strategies for simple to highly complex study designs without programming, and mid-study changes can be implemented in real time without migration processes. Oracle describes Clinical One as the only platform that unifies people, processes, and data for both traditional and decentralized trial designs.

Best suited for: Organizations with complex trial designs requiring unified EDC, RTSM, and safety management, particularly those already within the Oracle Life Sciences ecosystem.

Veeva Vault EDC

Veeva Systems (NYSE: VEEV) positions Vault EDC as part of the Veeva Clinical Platform — a connected suite that includes CTMS, eTMF, RTSM, eCOA, Study Training, and clinical data management tools on a single cloud architecture. Data flows bidirectionally between Vault EDC and other Veeva applications, eliminating reconciliation between separate systems.

Vault EDC features a visual drag-and-drop study designer that enables study builders to configure trials without writing code. The platform supports zero-downtime amendments, meaning study changes can be deployed to active trials without taking the system offline or migrating data — a meaningful operational advantage for long-running studies with frequent protocol modifications. According to Veeva, pharmaceutical company GSK achieved a 50% reduction in study build times using the platform.

The broader Veeva ecosystem provides strong integration across clinical operations, with features like site-level enrollment tracking, automated document exchange, and payment management. In 2025, Veeva announced plans for AI Agents across its applications, built on large language models from Anthropic and Amazon, with clinical operations capabilities expected to roll out through 2026.

Best suited for: Sponsors and CROs seeking a unified clinical operations and data management platform, particularly organizations that value tight integration between EDC, CTMS, and eTMF.

Mid-Market EDC Platforms

Viedoc

Viedoc, headquartered in Uppsala, Sweden, has grown from a Nordic-focused EDC provider into a globally recognized platform. Founded in 2003, the company has powered more than 7,000 clinical studies with over 1.6 million subjects across more than 75 countries. Viedoc was named a Leader in Everest Group's 2024 Life Sciences EDC Products PEAK Matrix Assessment — one of only a small number of vendors to receive this designation — and a Major Contender in the 2025 eCOA assessment.

The platform uses a low-code, drag-and-drop design approach through Viedoc Designer, enabling study teams to build and modify eCRFs without specialized programming skills. Viedoc operates cloud instances in the US, EU, China, and Japan, supporting regional data residency requirements. The system is localized in over 14 languages and holds ISO 27001 certification.

A distinctive strength of Viedoc is the integrated eClinical suite. EDC, ePRO, eConsent, eCOA, and RTSM modules are built within a single platform using one design tool, which avoids the data silos and reconciliation challenges that arise when these functions are managed by separate vendors. Viedoc is known in the market for its flexible, modular pricing model, which clients have highlighted as offering strong value relative to enterprise alternatives.

Best suited for: Mid-size pharmaceutical and biotech companies, CROs, and medical device companies seeking an intuitive, cost-effective platform that scales from single-site to multi-country studies.

Castor EDC

Castor is a modern, API-first EDC platform recognized for its rapid study deployment and strong capabilities in eCOA, eConsent, and decentralized trial support. The platform is designed to be accessible to both academic researchers and commercial trial sponsors, with an emphasis on user-friendliness and fast setup times. According to published information, new organizations starting a clinical trial in Castor require an average of one to three hours of training.

Castor supports online and offline data capture, real-time edit checks, and CDASH-compliant form templates. The platform is 21 CFR Part 11 compliant, HIPAA compliant, and ISO 27001 certified. Its cloud-based infrastructure uses military-grade encryption (ISO 27001) with off-site backups and SSL-encrypted data transfer.

The platform has expanded its feature set to include modules for direct data capture from patients, enabling hybrid and decentralized trial designs. Castor has positioned itself as particularly strong for medical device trials and smaller pharma studies where rapid deployment and intuitive interfaces are priorities.

Best suited for: Academic institutions, biotech startups, medical device companies, and small to mid-size sponsors requiring fast deployment and accessible pricing.

Medrio

Medrio delivers a unified cloud-based platform covering EDC, eCOA/ePRO, eConsent, direct data capture, and RTSM. The platform uses a no-code approach with drag-and-drop CRF builders and real-time edit checks. Medrio supports both online and offline data capture — relevant for sites with unreliable connectivity — and is 21 CFR Part 11 compliant. Its site-centric workflows and decentralized trial modules make it popular among small to mid-size sponsors who need comprehensive functionality without enterprise-level complexity.

Best suited for: Small to mid-size sponsors and CROs running hybrid or decentralized trials who need rapid deployment and flexible data capture.

TrialOnline (Replior)

TrialOnline, developed by Replior, is a cloud-based EDC platform designed to support efficient data capture and streamlined clinical trial execution for small to mid-size studies. The system emphasizes simplicity and rapid deployment, with a user-friendly interface that enables study teams to design and launch eCRFs without extensive programming expertise. TrialOnline supports real-time data validation, query management, and role-based access controls to ensure data quality and regulatory compliance.

A notable strength of TrialOnline is its integrated approach to clinical data management workflows. The platform includes modules for project management, monitoring, and reporting within a single environment, reducing the need for multiple disconnected systems. TrialOnline is compliant with key regulatory requirements including FDA 21 CFR Part 11 and GDPR, and is designed to support both traditional and decentralized trial models.

Best suited for: Small to mid-size sponsors, CROs, and academic research groups seeking a straightforward, cost-effective EDC platform with integrated project management capabilities.

eCaseLink (DSG)

eCaseLink, developed by DSG (Data Sciences Group), is an established EDC platform with a strong track record in supporting Phase I–IV clinical trials across a range of therapeutic areas. The system is designed to balance flexibility with robustness, offering configurable eCRF design, comprehensive edit check functionality, and efficient data review workflows. eCaseLink supports both online and offline data capture, making it suitable for studies involving sites with limited or variable internet connectivity.

The platform provides a broad set of data management tools, including medical coding integration, query management, audit trails, and reporting capabilities. DSG also offers complementary services such as database design, data management, and biostatistics, allowing sponsors to combine technology and functional support. eCaseLink is compliant with global regulatory standards including FDA 21 CFR Part 11 and is widely used by CROs and sponsors requiring reliable, service-backed EDC solutions.

Best suited for: Mid-size pharmaceutical companies, CROs, and sponsors looking for a proven EDC platform combined with full-service data management support.

Academic and Open-Source Solutions

OpenClinica

OpenClinica offers an open-source EDC platform that has supported more than 15,000 studies and managed data for over three million patients worldwide, according to the company. The platform combines a no-code interface with automation capabilities for study design, data capture, compliance, and reporting.

OpenClinica provides EHR-to-EDC connectivity for automated data acquisition, web service integration with external systems such as CTMS and laboratory platforms, and API access for custom integrations. The open-source foundation gives organizations the ability to customize the platform to their specific requirements, though this requires internal technical capability.

The platform is used by life sciences companies, academic institutions, and government agencies. For organizations with strong in-house technical teams, OpenClinica provides a cost-effective foundation that can be tailored extensively, though the trade-off is greater reliance on internal resources for system management and validation.

Best suited for: Academic medical centers, government research organizations, and sponsors with strong internal IT capabilities who need a customizable, cost-effective EDC foundation.

REDCap Cloud

REDCap Cloud provides a secure, cloud-based platform for academic and non-profit research. Building on the widely used REDCap framework developed at Vanderbilt University, REDCap Cloud adds commercial-grade hosting, validated environments, and 21 CFR Part 11 compliance features. Researchers familiar with REDCap can transition to the cloud version with minimal additional training. The platform supports real-time insights and multi-study data management.

Best suited for: Academic researchers, non-profit organizations, and investigator-initiated studies requiring an affordable, familiar platform with regulatory compliance capabilities.

Market Trends Shaping EDC Vendor Selection in 2026

Several trends are influencing how organizations evaluate EDC vendors today. These shifts are visible across vendor roadmaps and sit at the heart of how an integrated EDC ecosystem is expected to look in the coming years.

Platform consolidation is accelerating. Sponsors and CROs are reducing vendor counts, driven by the high cost of integrating disparate systems. Vendors offering EDC within broader integrated suites have a significant competitive advantage.

AI and machine learning capabilities are moving into production. Medidata's Clinical Data Studio, Oracle's AI-enabled EHR interoperability, and Veeva's planned AI Agents represent concrete implementations that automate data review and reduce manual effort.

Decentralized trial support has become a baseline requirement. All major vendors now offer patient-facing data entry, remote monitoring, and device integration. The maturity of these features varies, making hands-on evaluation essential.

EHR interoperability is emerging as critical. Pulling verified patient data from EHR systems directly into EDC reduces transcription errors and supports the FDA's vision of aligning clinical research with clinical care.

Choosing the Right Vendor for Your Organization

Selecting an EDC platform requires a structured assessment that accounts for the complexity and geographic scope of your clinical programs, the importance of integration with other eClinical systems, your internal technical resources, pricing models and total cost of ownership, and the vendor's regulatory compliance track record. Whichever platform you choose, validation and user training are essential steps before the first patient is enrolled.

TriTiCon's clinical data management training programs provide comprehensive coverage of the clinical technology landscape, including EDC system setup, eCRF design principles, and the data management processes that surround every EDC implementation. Explore the TriTiCon course platform and free resources.

Frequently Asked Questions

Which EDC vendor has the largest market share?

Medidata Rave EDC, a Dassault Systèmes brand, is widely recognized as the market leader based on the number of trials conducted, registered users, and industry analyst assessments. However, market share should be one of many factors in vendor selection — the best platform for your organization depends on your specific trial requirements, budget, and integration needs.

Are open-source EDC systems suitable for regulated clinical trials?

Yes, platforms like OpenClinica can be used for regulated clinical trials when properly validated. The key requirement is that the system meets applicable regulatory standards including FDA 21 CFR Part 11 and ICH GCP. Open-source systems may require more internal effort for validation and ongoing system management compared to commercially hosted platforms.

How often should an organization re-evaluate its EDC vendor?

Most organizations conduct formal EDC vendor assessments every three to five years, or when significant changes occur in their trial portfolio, regulatory requirements, or the vendor landscape. However, ongoing monitoring of your current platform's performance, vendor roadmap alignment, and emerging capabilities is recommended as part of regular technology governance.

This article is part of TriTiCon's USA Technology content series on clinical data management. For a comprehensive overview of EDC technology fundamentals, see our Complete Guide to EDC Systems in Clinical Trials (2026).

What is the best EDC system for small CROs in 2026?

For small CROs running multiple trials in parallel, the platforms most commonly evaluated are Viedoc (mid-market leader with modular pricing), Medrio (no-code build, strong DCT support), and Castor (rapid deployment, accessible for both academic and commercial trials). The right choice depends on therapeutic area focus, integration requirements, and whether you need ePRO and eCOA in the same platform. Enterprise platforms like Medidata Rave are typically over-sized for small CRO portfolios.

What is the best EDC system for biotech companies?

Biotech selection often prioritises rapid study startup, flexible eCRF design, and total cost of ownership across a small but variable trial portfolio. Castor, Viedoc, and Medrio are the platforms most frequently selected for this profile. For biotechs with a clear path to Phase III at a major sponsor, Medidata Rave or Veeva Vault EDC may be considered earlier to avoid mid-programme migrations.

What is the best EDC system for mid-size pharmaceutical companies?

Mid-size pharma typically benefits from platforms that offer enterprise capabilities without enterprise complexity. Viedoc has been named a Leader by Everest Group in this segment; Veeva Vault EDC offers tight integration across CTMS, eTMF, and EDC; and eCaseLink combines configurable EDC with full-service data management support. The deciding factors are usually integration depth with existing Veeva or Oracle systems, sourcing model (in-house vs CRO-led), and standards library re-use across trials.

Related articles: